STOCK TITAN

Blackrock Health Sciences Trust (BME) Stock Price, News & Analysis

BME NYSE
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
0 252 sessions, November 19, 2025 to November 19, 2026
Largest daily move
-3.9% close of March 27, 2026
1-year change
+11.1% closing prices, November 19, 2025 to November 19, 2026
1-month change
+0.3% closing prices, October 19, 2026 to November 19, 2026

Company Description

Blackrock Health Sciences Trust (BME) is a closed-end investment fund focused on the finance and insurance sector, within the securities and commodity exchanges industry. According to its stated investment objective, the trust seeks to provide total return through a combination of current income, current gains, and long-term capital appreciation. It does this by investing primarily in equity securities of companies engaged in health sciences and related industries, as well as in equity derivatives.

The trust’s strategy, as described in available information, is to invest at least 80% of its total assets in equity securities of health sciences companies and related industries and in equity derivatives. This focus on health sciences means the portfolio is concentrated in businesses connected to healthcare and related fields, while the use of equity derivatives is intended to support the objective of generating current income, gains, and capital appreciation over time.

Investment Objective and Strategy

The core objective of Blackrock Health Sciences Trust is to generate a total return that combines:

  • Current income
  • Current gains
  • Long-term capital appreciation

To pursue this objective, the fund states that it invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This approach aligns the trust with the performance and developments of the health sciences space, while also allowing it to use derivatives linked to equity markets as part of its strategy.

Sector and Industry Classification

For classification purposes on Stock Titan, Blackrock Health Sciences Trust is associated with the Finance and Insurance sector and the Securities and Commodity Exchanges industry. This reflects its structure as an investment vehicle whose shares trade in public markets and whose primary activity is investing in securities rather than producing or selling health-related products or services directly.

Health Sciences Focus

The trust’s emphasis on companies engaged in health sciences and related industries means its portfolio is tied to businesses operating in or around the broader healthcare ecosystem. While specific holdings are not detailed in the provided information, the mandate clearly links the fund’s investments to equity securities in that area and to equity derivatives connected to those markets.

Use of Equity Derivatives

Available information notes that Blackrock Health Sciences Trust invests in equity derivatives alongside equity securities. These instruments are used as part of the trust’s effort to achieve its stated objectives of current income, current gains, and long-term capital appreciation. The exact types of derivatives or strategies are not specified in the provided data, but their inclusion is a defined part of the investment approach.

Relationship to BlackRock

The trust carries the Blackrock name, indicating association with the broader BlackRock fund family. Separate news items describe BlackRock, Inc. as a fiduciary to investors and a provider of financial technology that helps people build savings by making investing easier and more affordable. However, the news materials focus on BlackRock at the corporate level and on other products and platforms, not on BME specifically, so they are best understood as general context about the sponsor brand rather than detailed information about this particular trust.

Trading and Investor Considerations

As an investment fund classified in the securities and commodity exchanges industry, Blackrock Health Sciences Trust is designed for investors who want exposure to health sciences and related industries through a professionally managed, exchange-traded vehicle. The fund’s objective and 80% investment policy are central reference points for understanding how it is intended to operate. Specific details such as current portfolio composition, distribution policy, or leverage, if any, are not provided in the available data and would need to be obtained from official fund documents.

Evergreen Characteristics

The elements that define Blackrock Health Sciences Trust in a durable way are its:

  • Stated objective of total return through current income, current gains, and long-term capital appreciation
  • Policy to invest 80% of total assets in equity securities of health sciences and related industries and in equity derivatives
  • Placement in the finance and insurance sector and securities and commodity exchanges industry

These characteristics describe the structural design of the trust rather than short-term performance or time-sensitive details, making them useful for long-term reference when researching the BME stock.

Stock Performance

$44.00
-1.01%
-0.45
After hoursChange vs the $44.45 closeLast updated: at
+11.1%
Performance 1 year
$568.7M

Blackrock Health Sciences Trust (BME) closed at $44.45 on November 19, 2026. Over the past 12 months, the price has gained 11.1%.

See what a $1,000 investment in BME would be worth today

Average down calculator for BME

BME Metrics & Rankings

Price returns through November 19, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

SEC Filings

Blackrock Health Sciences Trust has filed 6 recent SEC filings, including 2 Form 3, 2 Form 4, 1 Form N-CEN, 1 Form N-CSR. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BME SEC filings →

Short Interest History

Last 12 Months

Short interest in Blackrock Health Sciences Trust (BME) currently stands at 22.8 thousand shares, down 23.4% from the previous reporting period, representing 0.2% of the shares outstanding. Since November 2025, short interest has increased by 83.0%.

Days to Cover History

Last 12 Months

Days to cover for Blackrock Health Sciences Trust (BME) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 2.3 days.

BME Company Profile & Sector Positioning

Blackrock Health Sciences Trust (BME) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE. Among dividend-paying stocks, BME ranks #421 by dividend yield.

Investors comparing BME often look at related companies in the same sector, including Brookfield Real Assets Income Fund Inc. (RA), BlackRock Enhanced Global Dividend Trust (BOE), Virtus Equity & Convertible Income Fund (NIE), BlackRock Multi-Sector Income Trust (BIT), and BlackRock Core BD TR (BHK). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BME's relative position within its industry.

Frequently Asked Questions

The current stock price of Blackrock Health Sciences Trust (BME) is $44.00 in after-hours trading as of November 19, 2026.

The market cap of Blackrock Health Sciences Trust (BME) is approximately $568.7M. Learn more about what market capitalization means .

Blackrock Health Sciences Trust (BME) is an investment fund associated with the finance and insurance sector and the securities and commodity exchanges industry. It is designed to invest primarily in equity securities of companies engaged in the health sciences and related industries, as well as in equity derivatives.

According to its stated mandate, the investment objective of Blackrock Health Sciences Trust is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

The trust states that it invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This links its portfolio to health sciences businesses and to derivatives tied to equity markets.

On Stock Titan, Blackrock Health Sciences Trust is classified in the Finance and Insurance sector and the Securities and Commodity Exchanges industry, reflecting its role as an investment vehicle whose main activity is investing in securities.

Yes. Available information notes that Blackrock Health Sciences Trust invests in equity derivatives alongside equity securities. These derivatives form part of the fund’s approach to pursuing current income, current gains, and long-term capital appreciation.

The trust’s stated policy is to invest 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This means health sciences and related industries are central to its investment focus.

Blackrock Health Sciences Trust seeks to generate returns by combining current income and current gains with long-term capital appreciation. It pursues this objective through investments in equity securities of health sciences and related industries and through equity derivatives, as described in its investment policy.

The trust carries the Blackrock name, indicating association with the wider BlackRock fund family. Separate news materials describe BlackRock, Inc. as a fiduciary to investors and a provider of financial technology, but these materials focus on the corporate parent rather than on BME specifically.